Efficacy and biomarker analysis of neoadjuvant carrizumab plus apatinib in patients with local advanced biliary tract cancers.

Jianhua Rao,Chen Wu,Hui Zhang,Xuehao Wang,Ling Lu,Feng Cheng,Dongsheng Chen

Efficacy and biomarker analysis of neoadjuvant carrizumab plus apatinib in patients with local advanced biliary tract cancers.

2021

Jianhua Rao
Chen Wu
Hui Zhang
Xuehao Wang
Ling Lu
Feng Cheng
Dongsheng Chen

e16126Background: Camrelizumab (anti-PD-1 antibody) plus apatinib (VEGFR2 inhibitor) as combination therapy is highly effective in advanced osteosarcoma, hepatocellular carcinoma and extensive-stag...

Keywords:

Internal medicine
Combination therapy
Medicine
Hepatocellular carcinoma
Biomarker Analysis
Osteosarcoma
in patient
Oncology
Biliary tract
Apatinib
Antibody

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations